CCR5 and neoplasm: Considering the body of evidence highlighting a favorable prognosis for cancers expressing these IFN-γ induced chemokines, disruption of the CXCR3 and/or CCR5 pathways to prevent Treg accumulation in tumors is unlikely to be effective for promoting tumor immunity.